Literature DB >> 2394158

Albuterol and spacer-induced atrial fibrillation.

C C Breeden1, B H Safirstein.   

Abstract

Albuterol used with a spacer device which induced atrial fibrillation is described. Inhaled sympathomimetics have been extensively studied for the treatment of asthma and have generally been found to be safe from cardiac arrhythmias. A review of the literature is presented.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2394158     DOI： 10.1378/chest.98.3.762

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  4 in total

1.  Comparison of levalbuterol and racemic albuterol based on cardiac adverse effects in children.

Authors:  Laura L Bio; Vincent J Willey; Cathy Y Poon
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

Review 2.  Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence.

Authors:  Ken M Kunisaki; Kathryn L Rice; Dennis E Niewoehner
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

3.  Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertension.

Authors:  Frank de Vries; Sander Pouwels; Madelon Bracke; Jan-Willem Lammers; Olaf Klungel; Hubert Leufkens; Tjeerd van Staa
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

4.  Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation.

Authors:  G Patrick Daubert; Vincent H Mabasa; Vivian W Y Leung; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.